Aspiriant LLC’s iShares Select U.S. REIT ETF ICF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-4,960
Closed -$302K 270
2022
Q2
$302K Hold
4,960
0.01% 211
2022
Q1
$352K Hold
4,960
0.02% 208
2021
Q4
$377K Hold
4,960
0.02% 201
2021
Q3
$325K Hold
4,960
0.02% 187
2021
Q2
$324K Buy
+4,960
New +$312K 0.02% 193
2017
Q3
Sell
-5,934
Closed -$300K 210
2017
Q2
$300K Sell
5,934
-39,684
-87% -$2M 0.03% 171
2017
Q1
$634K Sell
45,618
-3,036
-6% -$152K 0.05% 137
2016
Q4
$644K Buy
48,654
+42,340
+671% +$2.08M 0.06% 125
2016
Q3
$331K Sell
6,314
-1,348
-18% -$72.9K 0.03% 160
2016
Q2
$415K Hold
7,662
0.04% 146
2016
Q1
$395K Hold
7,662
0.04% 142
2015
Q4
$380K Hold
7,662
0.04% 66
2015
Q3
$355K Hold
7,662
0.03% 80
2015
Q2
$343K Sell
7,662
-3,026
-28% -$145K 0.03% 83
2015
Q1
$540K Sell
10,688
-3,182
-23% -$162K 0.07% 57
2014
Q4
$672K Sell
13,870
-2,512
-15% -$117K 0.09% 51
2014
Q3
$692K Sell
16,382
-1,320
-7% -$58.3K 0.1% 43
2014
Q2
$773K Sell
17,702
-3,498
-17% -$151K 0.11% 52
2014
Q1
$872K Hold
21,200
0.13% 56
2013
Q4
$792K Buy
+21,200
New +$820K 0.12% 47
2013
Q3
Sell
-32,800
Closed -$1.32M 54
2013
Q2
$1.32M Buy
+32,800
New +$1.4M 0.21% 28

Other funds holding ICF

Aspiriant LLC's ICF Position: Q3 2022 in Review

Aspiriant LLC sold out of iShares Select U.S. REIT ETF (ICF) in Q3 2022, closing a stake of 4,960 shares — an estimated $302K sold.

Aspiriant LLC first reported a position in ICF in Q2 2013 and held it in 21 quarters. The position peaked at $1.32M in Q2 2013. 351 funds tracked by Wall St. Rank hold ICF as of Q3 2022.

  • Aspiriant LLC reported no remaining iShares Select U.S. REIT ETF position as of Q3 2022 after selling out during the quarter.
  • Aspiriant LLC sold 4,960 iShares Select U.S. REIT ETF shares in Q3 2022, an estimated $302K.
  • Aspiriant LLC first reported a position in iShares Select U.S. REIT ETF in Q2 2013 and held it in 21 quarters.
  • Aspiriant LLC's iShares Select U.S. REIT ETF position peaked at $1.32M in Q2 2013.
  • 351 funds tracked by Wall St. Rank held iShares Select U.S. REIT ETF as of Q3 2022.

Based on Aspiriant LLC's 13F filing for Q3 2022, filed 28 Oct 2022.